NEW YORK, April 27, 2021 /PRNewswire/ —
The sexually transmitted disease (STD) testing market is expected to grow by USD 74.64 million during 2021-2025, according to Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the sexually transmitted disease (STD) testing market in optimistic, probable, and pessimistic forecast scenarios.
Enterprises will go through the Response, Recovery, and Renew phases.
Download FREE Sample Report
The sexually transmitted disease (STD) testing market will witness a neutral impact during the forecast period, owing to the widespread growth of the COVID-19 pandemic. As per Technavio’s pandemic-focused market research, market growth is likely to increase in 2021 as compared to 2020.
With the continuing spread of the novel coronavirus pandemic, organizations across the globe are gradually flattening their recessionary curve by leveraging technology. Many businesses will go through response, recovery, and renewal phases. Building business resilience and enabling agility will aid organizations to move forward in their journey out of the COVID-19 crisis towards the Next Normal.
This post-pandemic business planning research will aid clients to:
- Adjust their strategic planning to move ahead once business stability kicks in.
- Build resilience by making effective resource and investment choices for individual business units, products, and service lines.
- Conceptualize scenario-based planning to mitigate future crisis situations.
Key Considerations for Market Forecast:
- Impact of lockdowns, supply chain disruptions, demand destruction, and change in customer behavior
- Optimistic, probable, and pessimistic scenarios for all markets as the impact of pandemic unfolds
- Pre- as well as post-COVID-19 market estimates
- Quarterly impact analysis and updates on market estimates
Major Three Sexually Transmitted Disease (STD) Testing Market Participants:
Abbott Laboratories offers real-time CT/NG assay that provides detection of Chlamydia trachomatis and Neisseria gonorrhoeae with proven clinical performance in sexually transmitted disease testing.
Becton, Dickinson, and Co.
Becton, Dickinson, and Co. offer ETEST Ceftazidime/Avibactam (CZA 256).
bioMerieux SA offers a variety of testing kit solutions.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Get a report snapshot here to get a detailed market share analysis of market participants during COVID-19 lockdown:
Sexually Transmitted Disease (STD) Testing Market 2021-2025: Segmentation
The sexually transmitted disease (STD) testing market is segmented as below:
- Laboratory Testing Devices
- POC Testing Devices
- North America
The sexually transmitted disease (STD) testing market is driven by factors such as increased initiatives by governments worldwide, the presence of favorable reimbursement policies, and the increasing prevalence of STDs. In addition, other factors such as the increasing involvement of various organizations to create awareness about STDs, advances that enable the rapid diagnosis of STDs, and approval of drugs and strong drug pipeline are expected to trigger the sexually transmitted disease (STD) testing market toward witnessing a CAGR of over 8% during the forecast period.
Get more insights about the global trends impacting the future of sexually transmitted disease (STD) testing market, Request Free Sample @
Related Report on Healthcare Include:
Global In Situ Hybridization Market– The in situ hybridization (ISH) market is segmented by technology (FISH and CISH), end-user (molecular diagnostic laboratories, pharmaceutical and biotechnological companies, and others), and geography (North America, Europe, Asia, and ROW). Download FREE Sample Report
Global Genetic Testing Market– The genetic testing market is segmented by product (equipment and consumables), application (predictive and diagnostic testing and pharmacogenomic testing), and geography (North America, Europe, Asia, and ROW). Download FREE Sample Report
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Report Page: https://www.technavio.com/report/sexually-transmitted-disease-std-testing-market-industry-analysis
View original content to download multimedia:http://www.prnewswire.com/news-releases/sexually-transmitted-disease-std-testing-market-to-grow-by-usd-74-64-million-during-2021-2025technavio-301277562.html